Trial Transparency Needed to Boost Trust
Dr. Jean-Louis Excler, Program Director, International Vaccine Institute
13-Aug-20 07:37
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
Russia has announced a Covid-19 vaccine, raising questions over the drug's safety and efficacy. Few details of the research have yet been released to the public, fuelling concerns that Russia's vaccine may not have fulfilled the required safety standards. So to help us answer the question of is this really the vaccine we're waiting for, we reached out to Dr. Jean-Louis Excler, Program Director at the International Vaccine Institute, an independent international organisation based in Seoul.
Image credit: AFP PHOTO / RUSSIAN DIRECT INVESTMENT FUND
Produced by: Dayana Mustak
Presented by: Roshan Kanesan, Lyn Mak, Noelle Lim
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: Politics, Law and Legal Matters, Health Policy, Diseases and Conditions, Mental Health, Healthy Living, Fitness, Science, Social Issues, Medical Innovation and Technology, Investments
Tags: covid-19, vaccine, russia, vladimir putin, trials, safety, healthcare, pharmaceuticals,